Abstract:INTRODUCTION: Short bowel syndrome (SBS) is an increasingly common condition encountered across neonatal intensive care units. Improvements in parenteral nutrition (PN), neonatal intensive care and surgical techniques, in addition to an improved understanding of SBS pathophysiology, have contributed in equal parts to the survival of this fragile subset of infants. Prevention of intestinal failure associated liver disease (IFALD) and promotion of intestinal adaptation are primary goals of all involved in the care of these patients. While enteral nutritional and pharmacological strategies are necessary to achieve these goals, there remains great variability in the application of therapeutic strategies in units that are not necessarily evidence-based.MATERIALS AND METHODS: A search of major English language medical databases (SCOPUS, Index Medicus, Medline, and the Cochrane database) was conducted for the key words short bowel syndrome, medical management, nutritional management and intestinal adaptation. All pharmacological and nutritional agents encountered in the literature search were classified based on their effects on absorptive capacity, intestinal adaptation and bowel motility that are the three major strategies employed in the management of SBS. The Oxford Center for Evidence-Based Medicine (CEBM) classification for levels of evidence was used to develop grades of clinical recommendation for each variable studied.RESULTS: We reviewed various medications used and nutritional strategies included soluble fiber, enteral fat, glutamine, probiotics and sodium supplementation. Most interventions have scientific rationale but little evidence to support their role in the management of infant SBS. While some of these agents symptomatically improve diarrhea, they can adversely influence pancreatico-biliary function or actually impair intestinal adaptation. Surgical anatomy and liver function are two important variables that should determine the selection of pharmacological and nutritional interventions.DISCUSSION: There is a paucity of research investigating optimal clinical practice in infant SBS and the little evidence available is consistently of lower quality, resulting in a wide variation of clinical practices among NICUs. Prospective trials should be encouraged to bridge the evidence gap between research and clinical practice to promote further progress in the field.

Research advances on oral feeding interventions for children with short bowel syndrome

[Advances in Nutritional Support for Children Undergoing Hematopoietic Stem Cell Transplantation].

A Review of Enteral Strategies in Infant Short Bowel Syndrome: Evidence-based or NICU Culture?

Strategies to Promote Success in Oral Feedings in Infants and Children with Intestinal Failure due to Short Bowel Syndrome

An overview of the current management of short-bowel syndrome in pediatric patients

Severe Short-Bowel Syndrome after Total Small Bowel Resection

Pathophysiology and clinical manifestations of short bowel syndrome

Navigating nutrition and hydration care in the adult patient with short bowel syndrome

Experience on Enteral Nutrition in Short Bowel Syndrome

Current treatment paradigms in pediatric short bowel syndrome

Short Bowel Syndrome: A Paradigm for Intestinal Adaptation to Nutrition?

Outcomes of Children With Short Bowel Syndrome: Experiences in a Multidisciplinary Intestinal Rehabilitation Unit Over Two Decades

Management of nutrition and contemporary treatment for short bowel syndrome

Early Intestinal Rehabilitation Therapy Ameliorates Intestinal Adaptation in Children with Short Bowel Syndrome: The Long-Term Outcome

Emerging treatments for short bowel syndrome in adult patients

Transition of Decade in Short Bowel Syndrome in China: Yesterday, Today, and Tomorrow

Advances in research on small intestinal bacterial overgrowth

Impact of intestinal lengthening on the nutritional outcome for children with short bowel syndrome

Morphological Adaptation In Adult Short Bowel Syndrome Undergoing Intestinal Rehabilitation

Systematic Review of Barriers and Facilitators to Complementary Feeding in Preterm Infants

Emerging drugs for the treatment of short bowel syndrome